Study of the biotransformation of a new sydnonimine derivative with predominant cerebral vasodilatory activity
Vadim Yu. Balabanyan (pharm@mail.ru)
Study of the biotransformation of a new sydnonimine derivative with predominant cerebral vasodilatory activity
DOI:
https://doi.org/10.18413/rrpharmacology.11.1042Abstract
Introduction: Sydnonimines are a promising group of drugs for development of novel substances with predominant cerebral vasodilatory activity. One of them is experimental compound with laboratory code BBP20233. The mechanism of action of BBP2023 compound is tied to its metabolites. This study aims for identification of...